| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1323703 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of UQCRB mRNA | CTD | PMID:22079256 |
| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of UQCRB mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UQCRB mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of UQCRB mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UQCRB mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1323703 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of UQCRB mRNA | CTD | PMID:23152189 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of UQCRB mRNA | CTD | PMID:20399798 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:1311971 | 6480464 | 2,6-dinitrotoluene affects the expression of UQCRB mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:1585163 | 6480464 | 2,6-dinitrotoluene affects the expression of UQCRB mRNA | CTD | PMID:21346803 |
| 5-fluorouracil | multiple interactions | ISO | RGD:1323703 | 6480464 | TP53 protein affects the reaction [Fluorouracil results in decreased expression of UQCRB mRNA] | CTD | PMID:15016801 |
| astaxanthin | multiple interactions | EXP | | 6480464 | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of UQCRB mRNA] | CTD | PMID:16964424 |
| bilirubin | decreases expression | ISO | RGD:1323703 | 6480464 | Bilirubin results in decreased expression of UQCRB mRNA | CTD | PMID:20196124 |
| clofibrate | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of UQCRB mRNA; more ... | CTD | PMID:17585979 |
| clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of UQCRB mRNA | CTD | PMID:17585979 |
| dibenz[a,h]anthracene | decreases expression | ISO | RGD:1323703 | 6480464 | 1,2,5,6-dibenzanthracene results in decreased expression of UQCRB mRNA | CTD | PMID:16269432 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of UQCRB mRNA | CTD | PMID:21266533 |
| disodium selenite | increases expression | ISO | RGD:1323703 | 6480464 | Sodium Selenite results in increased expression of UQCRB mRNA | CTD | PMID:18175754 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of UQCRB protein | CTD | PMID:16144979 |
| elemental selenium | decreases expression | ISO | RGD:1323703 | 6480464 | Selenium results in decreased expression of UQCRB mRNA | CTD | PMID:19244175 |
| hydralazine | multiple interactions | ISO | RGD:1323703 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of UQCRB mRNA | CTD | PMID:17183730 |
| lamivudine | multiple interactions | EXP | | 6480464 | [Zidovudine co-treated with Lamivudine] results in increased expression of UQCRB mRNA | CTD | PMID:18313992 |
| mercury atom | increases expression | ISO | RGD:1323703 | 6480464 | Mercury results in increased expression of UQCRB mRNA | CTD | PMID:16823088 |
| mercury(0) | increases expression | ISO | RGD:1323703 | 6480464 | Mercury results in increased expression of UQCRB mRNA | CTD | PMID:16823088 |
| mifepristone | increases expression | ISO | RGD:1323703 | 6480464 | Mifepristone results in increased expression of UQCRB mRNA | CTD | PMID:17584828 |
| paracetamol | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of UQCRB mRNA; more ... | CTD | PMID:17585979 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of UQCRB mRNA | CTD | PMID:22610192 |
| rosiglitazone | affects expression | EXP | | 6480464 | rosiglitazone affects the expression of UQCRB mRNA | CTD | PMID:22013433 |
| rotenone | increases expression | ISO | RGD:1323703 | 6480464 | Rotenone results in increased expression of UQCRB mRNA | CTD | PMID:18191903 |
| selenium atom | decreases expression | ISO | RGD:1323703 | 6480464 | Selenium results in decreased expression of UQCRB mRNA | CTD | PMID:19244175 |
| tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of UQCRB mRNA | CTD | PMID:17555576 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of UQCRB mRNA | CTD | PMID:22610192 |
| valproic acid | multiple interactions | ISO | RGD:1323703 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of UQCRB mRNA | CTD | PMID:17183730 |
| valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of UQCRB mRNA | CTD | PMID:17292431 |
| zidovudine | multiple interactions | EXP | | 6480464 | [Zidovudine co-treated with Lamivudine] results in increased expression of UQCRB mRNA | CTD | PMID:18313992 |